Olga Carroll, Ph.D.
Director, Regulatory Affairs - Oncology, Rare Disease, Neurology & Neurodegenerative Disease at Mallinckrodt Pharma
LINKS
olgacarroll@aol.com
516-343-3023
https://www.facebook.com/pages/OC-Consulting-LLC/128724110537401?ref_type=bookmark
516-343-3023
https://www.facebook.com/pages/OC-Consulting-LLC/128724110537401?ref_type=bookmark
Experience
Director, Regulatory Affairs - Oncology, Neurology & Neurodegenerative Disease
Mallinckrodt Pharmaceuticals
GRA, Clinical, Compliance Strategy, Competitive Intelligence
OC Consulting, LLC
I provide a variety of GRA, global policy, intelligence and strategy, clinical, medical, CMC, Compliance, QA, PV and PM services to my clients in the US, EU, AP, Eastern Europe, Northern Africa and Latin America.
OC Consulting, LLC logo
Director, Global Regulatory Affairs Oncology, Neurology, Full Time Consultant
NexGenix Pharmaceuticals
Deputy Director, Global Regulatory Affairs Strategy - TA -Oncology
Bayer HealthCare
VP, Regulatory Affairs and Compliance
Syntho-Intermax Pharmaceuticals, Inc.
Courses
OC Consulting, LLC
- Pharmaceutical Development with Focus on Japan and Asia Pacific Region to Gain Regulatory Approval in Therapeutic Areas where High Unmet Medical Need Exists (www.pvcertification.com)
Education
Additional Info
Interests
Advice for Contacting Olga
olgacarroll@aol.com
516-343-3023
https://www.facebook.com/pages/OC-Consulting-LLC/128724110537401?ref_type=bookmark
Mallinckrodt Pharma
//////////
Olga Kurylenko için tıklayın: olga kurylenko
ReplyDelete